The national antimicrobial resistance monitoring mission Primo publishes its annual report (2022 results)
The Primo mission (Prevention and control of infection in medico-social establishments and community care) aims to monitor and prevent antibiotic resistance and infections associated with healthcare, in community care and in the medico-social sector. Each year, it publishes its report dedicated to monitoring antibiotic resistance in a specific framework. The latest results are available. Access the publication “Monitoring bacterial resistance to antibiotics in community care and residential establishments for dependent…
Weekly Digest Nr 10 – Week 11 – 2024/03/15
Weekly Digest Nr 09 – Week 10 – 2024/03/08
Prevention and control of antimicrobial resistance in the food chain: WHO guidelines
In 2011, the World Health Organization (WHO) Regional Office for Europe published a document entitled “Addressing antibiotic resistance from a food security perspective in Europe”. It explored options for preventing and containing antibiotic resistance in the food chain through national coordination and international cooperation. Over the past decade, significant progress has been made and good results have been achieved. However, foodborne antimicrobial resistance remains a problem in the WHO European…
The PROMISE newsletter n°25 for February 2024 has been published
The latest edition of the PROMISE newsletter is online. This newsletter n°25 for the month of February 2024 offers you the latest news relating to antimicrobial resistance and the One Health global approach, from a perspective of disseminating information. On the program in particular: Featured WHO publishes list of medically important antimicrobials for human medicine A new platform for collecting data on sales and use of antimicrobials in animals [Save…
[Save The Date] AntibioDEAL Days on April 8 and 9, 2024 at Kremlin-Bicêtre
To combat the silent pandemic of antibiotic resistance, the PROMISE professional meta-network was set up as part of the Priority Antibiotic Resistance Research Plan. The emerging AntibioDEAL network is part of this program and aims to structure research and development into anti-infective agents at the national level and foster a collaborative environment. AntibioDEAL’s aims also to identify and remove the scientific and technological barriers to the discovery of anti-infective agents,…
WHO publishes the Medically Important Antimicrobials List for Human Medicine
To preserve their public health benefits, the responsible and prudent use of antimicrobials needs to be improved in all sectors – human, animal and environment. In particular, antimicrobials that are medically important for human medicine need to be preserved by reducing their use in the non-human sectors. That’s why the WHO publishes the list of medically important antimicrobials for human medicine (WHO MIA List). It’s a risk management tool that…
A new platform for collection of sales and use data of antimicrobials in animals
The collection of data on the sales and use of antimicrobials in animals has always been critical in the fight against antimicrobial resistance. As of January 2024, all Member States in the European Union (EU) and European Economic Area (EEA) must submit these data annually to the Antimicrobial Sales and Use (ASU) Platform. This new obligation was introduced by the Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6) as one of…
The PROMISE newsletter n°24 for January 2024 has been published
The latest edition of the PROMISE newsletter is online. This newsletter n°24 for the month of January 2024 offers you the latest news relating to antimicrobial resistance and the One Health global approach, from a perspective of disseminating information. On the program in particular: Featured The High Council for Public Health (HCSP) publishes a list of priority infectious diseases JPIAMR: a call for transnational projects to better prevent antimicrobial resistance…